Pathogenicity and Immunogenicity of Attenuated, nef-deleted HIV-1 Strains In Vivo

DSpace/Manakin Repository

Pathogenicity and Immunogenicity of Attenuated, nef-deleted HIV-1 Strains In Vivo

Citable link to this page

. . . . . .

Title: Pathogenicity and Immunogenicity of Attenuated, nef-deleted HIV-1 Strains In Vivo
Author: Gorry, Paul R; McPhee, Dale A; Verity, Erin; Dyer, Wayne B; Wesselingh, Steven L; Learmont, Jennifer; Roche, Michael; Zaunders, John J; Crowe, Suzanne M; Lewin, Sharon R; Brew, Bruce J; Cunningham, Anthony L; Churchill, Melissa J; Sullivan, John S.; Gabuzda, Dana Helga; Mills, John

Note: Order does not necessarily reflect citation order of authors.

Citation: Gorry, Paul R., Dale A. McPhee, Erin Verity, Wayne B. Dyer, Steven L. Wesselingh, Jennifer Learmont, John S. Sullivan, et al. 2007. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology 4: 66.
Full Text & Related Files:
Abstract: In efforts to develop an effective vaccine, sterilizing immunity to primate lentiviruses has only been achieved by the use of live attenuated viruses carrying major deletions in nef and other accessory genes. Although live attenuated HIV vaccines are unlikely to be developed due to a myriad of safety concerns, opportunities exist to better understand the correlates of immune protection against HIV infection by studying rare cohorts of long-term survivors infected with attenuated, nef-deleted HIV strains such as the Sydney blood bank cohort (SBBC). Here, we review studies of viral evolution, pathogenicity, and immune responses to HIV infection in SBBC members. The studies show that potent, broadly neutralizing anti-HIV antibodies and robust CD8+ T-cell responses to HIV infection were not necessary for long-term control of HIV infection in a subset of SBBC members, and were not sufficient to prevent HIV sequence evolution, augmentation of pathogenicity and eventual progression of HIV infection in another subset. However, a persistent T-helper proliferative response to HIV p24 antigen was associated with long-term control of infection. Together, these results underscore the importance of the host in the eventual outcome of infection. Thus, whilst generating an effective antibody and CD8+ T-cell response are an essential component of vaccines aimed at preventing primary HIV infection, T-helper responses may be important in the generation of an effective therapeutic vaccine aimed at blunting chronic HIV infection.
Published Version: doi:10.1186/1742-4690-4-66
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075523/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8231695

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters